Alberta Investment Management Corp Gilead Sciences, Inc. Transaction History

Alberta Investment Management Corp

$10.2 Billion
Q3 2024

A detailed history of Alberta Investment Management Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Alberta Investment Management Corp holds 901,193 shares of GILD stock, worth $81.3 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

901,193

Previous 900,283 0.1%

Holding current value

$81.3 Million

Previous $61.8 Million 22.29%

% of portfolio

0.74%

Previous 0.74%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$66.59 - $83.99 $60,596 - $76,430	910 Added 0.1%	901,193 $75.5 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $5.24 Million - $6.04 Million	82,900 Added 10.14%	900,283 $61.8 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $7.36 Million - $8.03 Million	-99,591 Reduced 10.86%	817,383 $61.3 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $24 Million - $27.3 Million	-310,217 Reduced 25.28%	916,974 $76.1 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $3.39 Million - $4.87 Million	-54,406 Reduced 4.25%	1,227,191 $105 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $643,032 - $734,508	-10,800 Reduced 0.84%	1,281,597 $79.1 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $8.39 Million - $9.45 Million	145,383 Added 12.67%	1,292,397 $79.9 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $10.1 Million - $12.6 Million	174,100 Added 17.89%	1,147,014 $68.2 Million
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $8.06 Million - $9.15 Million	124,231 Added 14.64%	972,914 $70.6 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $5.92 Million - $6.38 Million	-87,400 Reduced 9.34%	848,683 $59.3 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $3.07 Million - $3.35 Million	-48,300 Reduced 4.91%	936,083 $64.5 Million
Q1 2021 May 07, 2021	BUY	$60.0 - $68.46 $3.21 Million - $3.66 Million	53,500 Added 5.75%	984,383 $63.6 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $3.38 Million - $3.85 Million	59,700 Added 6.85%	930,883 $54.2 Million
Q3 2020 Oct 26, 2020	BUY	$62.1 - $78.08 $5.6 Million - $7.04 Million	90,200 Added 11.55%	871,183 $55.1 Million
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $12.5 Million - $14.5 Million	172,900 Added 28.43%	780,983 $60.1 Million
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $9.4 Million - $12 Million	-150,100 Reduced 19.8%	608,083 $45.5 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $25.5 Million - $28 Million	-413,600 Reduced 35.3%	758,183 $49.3 Million
Q3 2019 Oct 23, 2019	BUY	$62.51 - $69.0 $11 Million - $12.2 Million	176,300 Added 17.71%	1,171,783 $74.3 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $21 Million - $23.5 Million	338,700 Added 51.57%	995,483 $67.3 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $6.42 Million - $7.19 Million	102,700 Added 18.54%	656,783 $42.7 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $16.4 Million - $21.4 Million	271,000 Added 95.73%	554,083 $34.7 Million
Q3 2018 Nov 16, 2018	BUY	$71.28 - $78.92 $3.54 Million - $3.91 Million	49,600 Added 21.24%	283,083 $21.9 Million
Q4 2017 Feb 15, 2018	SELL	$71.15 - $83.52 $1.53 Million - $1.8 Million	-21,500 Reduced 8.43%	233,483 $16.7 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $18.4 Million - $21.8 Million	254,983	254,983 $20.7 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Account

Alberta Investment Management Corp Gilead Sciences, Inc. Transaction History